Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with Massdevice +7.
7. BlackRock takes a chunk out of Wright, cashes out on Varian, Orthofix and Conceptus
BlackRock Inc. (NYSE:BLK) is cashing in some of its chips in a clutch of medical device companies at the same time as it put more skin into Wright Medical Group Inc. (NSDQ:WMGI), according to regulatory filings.
6. SEC calls foul on baseball Hall of Famer for insider trading on Abbott Labs.
The SEC charged former Orioles baseball player Doug DeCinces alongside three others with insider trading ahead of an Abbott (NYSE:ABT) acquisition, raking in $1.7 million in illegal profits.
5. SNN whistleblower demands sales docs
A former Smith & Nephew (NYSE:SNN) executive wants a Tennessee federal court to force the company to cough up documents detailing its sales to the U.S. government.
4. Italy tackles Siemens, Philips and Toshiba on antitrust charges
The Italian Antitrust Authority charged Siemens SpA (NYSE:SI), Philips SpA and Toshiba Medical Systems Italia Srl a total of about $7.4 million on conspiracy to control certain medical device supply lines. GE Healthcare’s Italian arm was the first to point the finger.
3. Medtronic steals the spotlight
2. Abbott and BSX vie for top spot in drug-eluting stents
1. Medtronic on insulin pump hacker: Not a big deal
A diabetic’s successful hack of his own insulin pump raised the spectre of malicious device-based attacks, but Medtronic Inc. (NYSE:MDT) doesn’t think there’s much to worry about.